Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
25%(3 trials)

Phase Distribution

Ph phase_1
9
75%
Ph phase_2
3
25%

Phase Distribution

9

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
9(75.0%)
Phase 2Efficacy & side effects
3(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(12)

Detailed Status

Completed12

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 19 (75.0%)
Phase 23 (25.0%)

Trials by Status

completed12100%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_1

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

NCT06362265
completedphase_1

A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes

NCT06169982
completedphase_1

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

NCT05596747
completedphase_1

A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus

NCT04957914
completedphase_2

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

NCT04450394
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06362265Phase 1

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Completed
NCT06169982Phase 1

A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes

Completed
NCT05596747Phase 1

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Completed
NCT04957914Phase 1

A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus

Completed
NCT04450394Phase 2

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Completed
NCT04450407Phase 2

A Study of LY3209590 in Participants With Type 1 Diabetes

Completed
NCT04768842Phase 1

A Study of Two Different Formulations of LY3209590 in Healthy Participants

Completed
NCT03736785Phase 2

A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Completed
NCT04276428Phase 1

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

Completed
NCT03603704Phase 1

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes

Completed
NCT03367377Phase 1

A Study of LY3209590 in Participants With Type 2 Diabetes

Completed
NCT02942914Phase 1

A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12